Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$23.0 - $29.01 $1.05 Million - $1.33 Million
-45,821 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$25.04 - $30.06 $2.09 Million - $2.51 Million
-83,607 Reduced 64.6%
45,821 $1.28 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $1.19 Million - $1.42 Million
-43,521 Reduced 25.16%
129,428 $3.8 Million
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $2.18 Million - $3.51 Million
-102,239 Reduced 37.15%
172,949 $5.49 Million
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $428,603 - $591,254
-27,995 Reduced 9.23%
275,188 $5.71 Million
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $520,413 - $704,026
-34,974 Reduced 10.34%
303,183 $4.7 Million
Q2 2020

Aug 14, 2020

SELL
$13.31 - $20.51 $361,646 - $557,277
-27,171 Reduced 7.44%
338,157 $6.17 Million
Q1 2020

May 14, 2020

SELL
$12.98 - $30.25 $5.89 Million - $13.7 Million
-453,958 Reduced 55.41%
365,328 $5.6 Million
Q4 2019

Feb 13, 2020

SELL
$18.89 - $31.89 $5.4 Million - $9.11 Million
-285,770 Reduced 25.86%
819,286 $24.6 Million
Q3 2019

Nov 13, 2019

SELL
$20.88 - $25.66 $1.57 Million - $1.93 Million
-75,075 Reduced 6.36%
1,105,056 $24.1 Million
Q2 2019

Aug 08, 2019

BUY
$20.52 - $26.45 $3.56 Million - $4.59 Million
173,614 Added 17.25%
1,180,131 $29.8 Million
Q1 2019

May 13, 2019

BUY
$20.23 - $26.29 $1.61 Million - $2.1 Million
79,707 Added 8.6%
1,006,517 $24.8 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $12.9 Million - $20.7 Million
730,778 Added 372.79%
926,810 $17.1 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $4.05 Million - $5.03 Million
196,032 New
196,032 $5.03 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.78B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.